EMEA-000551-PIP04-21-M02
Submitted by Anonymous (not verified) on 5 July 2024 - 13:07
EMEA-000551-PIP04-21-M02
Opinion/decision on a Paediatric investigation plan (PIP): Noxafil, posaconazole, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0200/2023
Submitted by Anonymous (not verified) on 5 July 2024 - 12:50
Opinion/decision on a Paediatric investigation plan (PIP): Noxafil, posaconazole, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0200/2023
EMEA-000347-PIP02-16-M05
Submitted by Anonymous (not verified) on 5 July 2024 - 12:47
EMEA-000347-PIP02-16-M05
EMEA-000207-PIP01-08-M08
Submitted by Anonymous (not verified) on 5 July 2024 - 12:41
EMEA-000207-PIP01-08-M08
Referral: Hydroxyprogesterone caproate-containing medicinal products, hydroxyprogesterone caproate, associated names: Lentogest,Progesterone Retard Pharlon,Proluton Depot Article 31 referrals CMDh final position, 05/07/2024
Submitted by Anonymous (not verified) on 5 July 2024 - 12:38
Referral: Hydroxyprogesterone caproate-containing medicinal products, hydroxyprogesterone caproate, associated names: Lentogest,Progesterone Retard Pharlon,Proluton Depot Article 31 referrals CMDh final position, 05/07/2024
2023 annual report of the European Medicines Agency
Submitted by Anonymous (not verified) on 5 July 2024 - 11:31
2023 annual report of the European Medicines Agency
Pharmacovigilance fees payable to the European Medicines Agency
Submitted by Anonymous (not verified) on 5 July 2024 - 9:54
Pharmacovigilance fees payable to the European Medicines Agency
New Fee Regulation working arrangements
Submitted by Anonymous (not verified) on 5 July 2024 - 9:41
New Fee Regulation working arrangements
Draft VICH GL23 Studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing - Revision 2
Submitted by Anonymous (not verified) on 5 July 2024 - 8:17
Draft VICH GL23 Studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing - Revision 2
Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 4, Status: Authorised
Submitted by Anonymous (not verified) on 4 July 2024 - 14:11
Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 4, Status: Authorised